ABSTRACT
Respiratory dysfunction is a notorious cause of perinatal mortality in infants and sleep apnoea in adults, but the mechanisms of respiratory control are not clearly understood. Mechanical signals transduced by airway-innervating sensory neurons control respiration; however, the physiological significance and molecular mechanisms of these signals remain obscured. Here we show that global and sensory neuron-specific ablation of the mechanically activated ion channel Piezo2 causes respiratory distress and death in newborn mice. Optogenetic activation of Piezo2+ vagal sensory neurons causes apnoea in adult mice. Moreover, induced ablation of Piezo2 in sensory neurons of adult mice causes decreased neuronal responses to lung inflation, an impaired Hering-Breuer mechanoreflex, and increased tidal volume under normal conditions. These phenotypes are reproduced in mice lacking Piezo2 in the nodose ganglion. Our data suggest that Piezo2 is an airway stretch sensor and that Piezo2-mediated mechanotransduction within various airway-innervating sensory neurons is critical for establishing efficient respiration at birth and maintaining normal breathing in adults.
Subject(s)
Apnea/physiopathology , Ion Channels/metabolism , Lung/physiology , Lung/physiopathology , Mechanotransduction, Cellular/physiology , Reflex/physiology , Animals , Animals, Newborn , Apnea/genetics , Death , Female , Ion Channels/deficiency , Ion Channels/genetics , Male , Mechanotransduction, Cellular/genetics , Mice , Nodose Ganglion/metabolism , Reflex/genetics , Respiration , Sensory Receptor Cells/metabolism , Tidal VolumeABSTRACT
Opioid peptides and their receptors are expressed in the mammalian retina; however, little is known about how they might affect visual processing. The melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs), which mediate important non-image-forming visual processes such as the pupillary light reflex (PLR), express ß-endorphin-preferring, µ-opioid receptors (MORs). The objective of the present study was to elucidate if opioids, endogenous or exogenous, modulate pupillary light reflex (PLR) via MORs expressed by ipRGCs. MOR-selective agonist [D-Ala2, MePhe4, Gly-ol5]-enkephalin (DAMGO) or antagonist D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP) was administered via intravitreal injection. PLR was recorded in response to light stimuli of various intensities. DAMGO eliminated PLR evoked by light with intensities below melanopsin activation threshold but not that evoked by bright blue irradiance that activated melanopsin signaling, although in the latter case, DAMGO markedly slowed pupil constriction. CTAP or genetic ablation of MORs in ipRGCs slightly enhanced dim-light-evoked PLR but not that evoked by a bright blue stimulus. Our results suggest that endogenous opioid signaling in the retina contributes to the regulation of PLR. The slowing of bright light-evoked PLR by DAMGO is consistent with the observation that systemically applied opioids accumulate in the vitreous and that patients receiving chronic opioid treatment have slow PLR.
Subject(s)
Opioid Peptides/genetics , Receptors, Opioid, mu/genetics , Retina/metabolism , Visual Perception/genetics , Animals , Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology , Enkephalins/antagonists & inhibitors , Enkephalins/genetics , Humans , Light , Mice , Peptides/pharmacology , Receptors, Opioid/genetics , Receptors, Opioid, mu/antagonists & inhibitors , Reflex/genetics , Retina/pathology , Retinal Ganglion Cells/metabolism , Retinal Ganglion Cells/physiology , Signal Transduction/drug effects , Visual Perception/drug effects , beta-Endorphin/geneticsABSTRACT
Habituation is a ubiquitous form of non-associative learning observed as a decrement in responding to repeated stimulation that cannot be explained by sensory adaptation or motor fatigue. One of the defining characteristics of habituation is its sensitivity to the rate at which training stimuli are presented-animals habituate faster in response to more rapid stimulation. The molecular mechanisms underlying this interstimulus interval (ISI)-dependent characteristic of habituation remain unknown. In this article, we use behavioural neurogenetic and bioinformatic analyses in the nematode Caenorhabiditis elegans to identify the first molecules that modulate habituation in an ISI-dependent manner. We show that the Caenorhabditis elegans orthologues of Ca2+/calmodulin-dependent kinases CaMK1/4, CMK-1 and O-linked N-acetylglucosamine (O-GlcNAc) transferase, OGT-1, both function in primary sensory neurons to inhibit habituation at short ISIs and promote it at long ISIs. In addition, both cmk-1 and ogt-1 mutants display a rare mechanosensory hyper-responsive phenotype (i.e. larger mechanosensory responses than wild-type). Overall, our work identifies two conserved genes that function in sensory neurons to modulate habituation in an ISI-dependent manner, providing the first insights into the molecular mechanisms underlying the universally observed phenomenon that habituation has different properties when stimuli are delivered at different rates.
Subject(s)
Caenorhabditis elegans Proteins/physiology , Caenorhabditis elegans/physiology , Calcium-Calmodulin-Dependent Protein Kinase Type 2/physiology , N-Acetylglucosaminyltransferases/physiology , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans Proteins/genetics , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Habituation, Psychophysiologic/genetics , N-Acetylglucosaminyltransferases/genetics , Reflex/geneticsABSTRACT
Photic sneeze syndrome (PSS) is characterized by a tendency to sneeze when the eye is exposed to bright light. Recent genome-wide association studies (GWASs) have identified single-nucleotide polymorphisms (SNPs) associated with PSS in Caucasian populations. We performed a GWAS on PSS in Japanese individuals who responded to a web-based survey and provided saliva samples. After quality control, genotype data of 210,086 SNPs in 11,409 individuals were analyzed. The overall prevalence of PSS was 3.2%. Consistent with previous reports, SNPs at 3p12.1 were associated with PSS at genome-wide significance (p < 5.0 × 10-8). Furthermore, two novel loci at 9q34.2 and 4q35.2 reached suggestive significance (p < 5.0 × 10-6). Our data also provided evidence supporting the two additional SNPs on 2q22.3 and 9q33.2 reportedly associated with PSS. Our study reproduced previous findings in Caucasian populations and further suggested novel PSS loci in the Japanese population.
Subject(s)
Genome-Wide Association Study , Sneezing/genetics , Adult , Asian People , Chromosomes, Human, Pair 3 , Female , Humans , Japan/epidemiology , Male , Middle Aged , Polymorphism, Single Nucleotide , Prevalence , Reflex/geneticsABSTRACT
This study elucidates genetic influences on reflexive (as opposed to sustained) attention in children (aged 9-16 years; N = 332) who previously participated as infants in visual attention studies using orienting to a moving bar (Dannemiller, 2004). We investigated genetic associations with reflexive attention measures in infancy and childhood in the same group of children. The genetic markers (single nucleotide polymorphisms and variable number tandem repeats on the genes APOE, BDNF, CHRNA4, COMT, DRD4, HTR4, IGF2, MAOA, SLC5A7, SLC6A3, and SNAP25) are related to brain development and/or to the availability of neurotransmitters such as acetylcholine, dopamine, or serotonin. This study shows that typically developing children have differences in reflexive attention associated with their genes, as we found in adults (Lundwall, Guo & Dannemiller, 2012). This effort to extend our previous findings to outcomes in infancy and childhood was necessary because genetic influence may differ over the course of development. Although two of the genes that were tested in our adult study (Lundwall et al., 2012) were significant in either our infant study (SLC6A3) or child study (DRD4), the specific markers tested differed. Performance on the infant task was associated with SLC6A3. In addition, several genetic associations with an analogous child task occurred with markers on CHRNA4, COMT, and DRD4. Interestingly, the child version of the task involved an interaction such that which genotype group performed poorer on the child task depended on whether we were examining the higher or lower infant scoring group. These findings are discussed in terms of genetic influences on reflexive attention in infancy and childhood.
Subject(s)
Attention/physiology , Reflex/genetics , Adolescent , Brain/growth & development , Child , Child Development , Dopamine Plasma Membrane Transport Proteins/genetics , Genetic Markers , Humans , Minisatellite Repeats , Polymorphism, Single Nucleotide , Receptors, Dopamine D4/geneticsABSTRACT
INTRODUCTION: Mutations in SCN1A have been reported in patients with different types of epilepsy, including generalized epilepsy with febrile seizures plus, severe myoclonic epilepsy in infancy, malignant migrating partial seizures in infancy, and other infantile epileptic encephalopathies. CASE REPORT: We report a case of a 10-month-old girl presented with reflex epileptic seizures provoked by somatosensory stimuli with a novel de novo mutation of SCN1A gene. She was observed to have seizures with eye deviation, unresponsiveness provoked by somatosensory stimuli of the face. Video-electroencephalography (EEG) revealed generalized spike-and-wave patterns. She experienced one or two focal clonic seizures per month over the 6 months while taking valproate and carbamazepine. At 22 months old, she was hospitalized with an episode of generalized tonic clonic febrile status epilepticus lasting for 45 min. Interictal sleep video-EEG showed sharp-and-slow wave discharges in the left occipital lobe with normal background activity. We found a de novo heterozygote mutation in SCN1A gene, c.1337A>C (p. Q422P). CONCLUSION: To our knowledge, this mutation has not been previously described in the SCN1A gene and this is the first report of epilepsy related to SCN1A mutation as a presenting with reflex epilepsy of somatosensory stimuli. This case report contributes to an expanding clinical spectrum of patients with SCN1A mutations.
Subject(s)
Epilepsy/genetics , Epilepsy/physiopathology , Evoked Potentials, Somatosensory/physiology , Mutation/genetics , NAV1.1 Voltage-Gated Sodium Channel/genetics , Reflex/genetics , DNA Mutational Analysis , Electroencephalography , Female , Humans , InfantABSTRACT
There are â¼20 types of retinal ganglion cells (RGCs) in mice, each of which has distinct molecular, morphological, and physiological characteristics. Each RGC type sends axon projections to specific brain areas that execute light-dependent behaviors. Here, we show that the T-box transcription factor Tbr2 is required for the development of several RGC types that participate in non-image-forming circuits. These types are molecularly distinct, project to non-image-forming targets, and include intrinsically photosensitive RGCs. Tbr2 mutant mice have reduced retinal projections to non-image-forming nuclei and an attenuated pupillary light reflex. These data demonstrate that Tbr2 acts to execute RGC type choice and/or survival in a set of RGCs that mediates light-induced subconscious behaviors.
Subject(s)
Axons/physiology , Gene Expression Regulation/physiology , Pupil/physiology , Reflex/physiology , T-Box Domain Proteins/metabolism , Visual Pathways/physiology , Age Factors , Animals , Animals, Newborn , Cadherins/genetics , Calbindin 2/genetics , Calbindin 2/metabolism , Female , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Male , Mice , Mice, Transgenic , Mutation/genetics , Receptors, Dopamine D4/genetics , Receptors, Dopamine D4/metabolism , Reflex/genetics , Retinal Ganglion Cells/cytology , Retinal Ganglion Cells/physiology , T-Box Domain Proteins/geneticsABSTRACT
OBJECTIVE: We recently reported a Q555X mutation of synapsin 1 (SYN1) on chromosome Xp11-q21 in a family segregating partial epilepsy and autistic spectrum disorder. Herein, we provide a detailed description of the epileptic syndrome in the original family. METHODS: A total of 34 members from a large French-Canadian family were evaluated. Family members with seizures or epilepsy underwent (when possible) clinical, neuropsychological, electrophysiologic, and neuroimaging assessments. RESULTS: Epilepsy was diagnosed in 10 family members (4 deceased, 6 living). In addition to occasional spontaneous complex partial seizures, seven family members clearly had reflex seizures triggered by bathing or showering. Hippocampal atrophy was found in two of five epileptic family members family members who underwent magnetic resonance (MR) imaging. Video-electroencephalography (EEG) recordings of three triggered seizures in two affected members showed rhythmic theta activity over temporal head regions. Ictal single-photon emission computed tomography (SPECT) showed temporoinsular perfusion changes. Detailed neuropsychological assessments revealed that SYN1 Q555X male mutation carriers showed specific language impairment and mild autistic spectrum disorder. Female carriers also exhibited reading impairments and febrile seizures but no chronic epilepsy. SIGNIFICANCE: Available evidence suggests that impaired SYN1 function is associated with hyperexcitability of the temporoinsular network and disturbance of high mental functions such as language and social interaction. The presence of reflex bathing seizures, a most peculiar clinical feature, could be helpful in identifying other patients with this syndrome.
Subject(s)
Baths/adverse effects , Epilepsies, Partial/genetics , Genetic Diseases, X-Linked/genetics , Reflex/genetics , Seizures/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Child , Epilepsies, Partial/diagnosis , Female , Genetic Diseases, X-Linked/diagnosis , Humans , Male , Middle Aged , Pedigree , Quebec , Seizures/diagnosis , SyndromeABSTRACT
Ingestive behaviors in mice are dependent on orosensory cues transmitted via the trigeminal nerve, as confirmed by transection studies. However, these studies cannot differentiate between deficits caused by the loss of the lemniscal pathway vs. the parallel paralemniscal pathway. The paired-like homeodomain protein Prrxl1 is expressed widely in the brain and spinal cord, including the trigeminal system. A knockout of Prrxl1 abolishes somatotopic barrellette patterning in the lemniscal brainstem nucleus, but not in the parallel paralemniscal nucleus. Null animals are significantly smaller than littermates by postnatal day 5, but reach developmental landmarks at appropriate times, and survive to adulthood on liquid diet. A careful analysis of infant and adult ingestive behavior reveals subtle impairments in suckling, increases in time spent feeding and the duration of feeding bouts, feeding during inappropriate times of the day, and difficulties in the mechanics of feeding. During liquid diet feeding, null mice display abnormal behaviors including extensive use of the paws to move food into the mouth, submerging the snout in the diet, changes in licking, and also have difficulty consuming solid chow pellets. We suggest that our Prrxl1(-/-) animal is a valuable model system for examining the genetic assembly and functional role of trigeminal lemniscal circuits in the normal control of eating in mammals and for understanding feeding abnormalities in humans resulting from the abnormal development of these circuits.
Subject(s)
Developmental Disabilities/genetics , Developmental Disabilities/physiopathology , Feeding Behavior/physiology , Nerve Tissue Proteins/deficiency , Transcription Factors/deficiency , Trigeminal Nucleus, Spinal/pathology , Afferent Pathways/physiology , Analysis of Variance , Animals , Animals, Newborn , Body Weight/genetics , Disease Models, Animal , Female , Homeodomain Proteins/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Tissue Proteins/genetics , Reflex/genetics , Smell/genetics , Transcription Factors/genetics , Vibrissae/innervationABSTRACT
Down syndrome (DS) is associated with neurological complications, including cognitive deficits that lead to impairment in intellectual functioning. Increased GABA-mediated inhibition has been proposed as a mechanism underlying deficient cognition in the Ts65Dn (TS) mouse model of DS. We show that chronic treatment of these mice with RO4938581 (3-bromo-10-(difluoromethyl)-9H-benzo[f]imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]diazepine), a selective GABA(A) α5 negative allosteric modulator (NAM), rescued their deficits in spatial learning and memory, hippocampal synaptic plasticity, and adult neurogenesis. We also show that RO4938581 normalized the high density of GABAergic synapse markers in the molecular layer of the hippocampus of TS mice. In addition, RO4938581 treatment suppressed the hyperactivity observed in TS mice without inducing anxiety or altering their motor abilities. These data demonstrate that reducing GABAergic inhibition with RO4938581 can reverse functional and neuromorphological deficits of TS mice by facilitating brain plasticity and support the potential therapeutic use of selective GABA(A) α5 NAMs to treat cognitive dysfunction in DS.
Subject(s)
Down Syndrome/complications , Down Syndrome/pathology , Hippocampus/pathology , Learning Disabilities/drug therapy , Neurons/physiology , Receptors, GABA-A/metabolism , Acoustic Stimulation , Analysis of Variance , Animals , Benzodiazepines/pharmacology , Benzodiazepines/therapeutic use , Biophysics , Carrier Proteins/metabolism , Cell Count , Cell Proliferation/drug effects , Cues , Disease Models, Animal , Down Syndrome/drug therapy , Electric Stimulation , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/genetics , Exploratory Behavior/drug effects , GABA Modulators/pharmacology , GABA Modulators/therapeutic use , Glutamate Decarboxylase/metabolism , Hippocampus/drug effects , Hyperkinesis/drug therapy , Hyperkinesis/etiology , Imidazoles/pharmacology , Imidazoles/therapeutic use , Ki-67 Antigen , Learning Disabilities/etiology , Long-Term Potentiation/drug effects , Long-Term Potentiation/genetics , Male , Maze Learning/drug effects , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neurogenesis/drug effects , Neurogenesis/genetics , Neurons/drug effects , Protein Binding/drug effects , Protein Binding/genetics , Psychomotor Performance/drug effects , Reaction Time/drug effects , Reflex/drug effects , Reflex/genetics , Reflex, Startle/drug effects , Rotarod Performance Test , Seizures/etiology , Sensory Gating/drug effects , Tritium/pharmacokinetics , Vesicular Inhibitory Amino Acid Transport Proteins/metabolismABSTRACT
Alzheimer's disease (AD) is a neurodegenerative disorder that represents the most common type of dementia among elderly people. Amyloid beta (Aß) peptides in extracellular Aß plaques, produced from the amyloid precursor protein (APP) via sequential processing by ß- and γ-secretases, impair hippocampal synaptic plasticity, and cause cognitive dysfunction in AD patients. Here, we report that Aß peptides also impair another form of synaptic plasticity; cerebellar long-term depression (LTD). In the cerebellum of commonly used AD mouse model, APPswe/PS1dE9 mice, Aß plaques were detected from 8 months and profound accumulation of Aß plaques was observed at 18 onths of age. Biochemical analysis revealed relatively high levels of APP protein and Aß in the cerebellum of APPswe/PS1dE9 mice. At pre-Aß accumulation stage, LTD induction, and motor coordination are disturbed. These results indicate that soluble Aß oligomers disturb LTD induction and cerebellar function in AD mouse model.
Subject(s)
Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Cerebellum/metabolism , Neuronal Plasticity/physiology , Presenilin-1/genetics , Presenilin-1/metabolism , Psychomotor Performance/physiology , Animals , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Humans , Immunohistochemistry , In Vitro Techniques , Mice , Mice, Transgenic , Peptide Fragments/metabolism , Reflex/genetics , Reflex/physiology , Synapses/physiologyABSTRACT
Neuregulin 1 acts as an axonal signal that regulates multiple aspects of Schwann cell development including the survival and migration of Schwann cell precursors, the ensheathment of axons and subsequent elaboration of the myelin sheath. To examine the role of this factor in remyelination and repair following nerve injury, we ablated neuregulin 1 in the adult nervous system using a tamoxifen inducible Cre recombinase transgenic mouse system. The loss of neuregulin 1 impaired remyelination after nerve crush, but did not affect Schwann cell proliferation associated with Wallerian degeneration or axon regeneration or the clearance of myelin debris by macrophages. Myelination changes were most marked at 10 days after injury but still apparent at 2 months post-crush. Transcriptional analysis demonstrated reduced expression of myelin-related genes during nerve repair in animals lacking neuregulin 1. We also studied repair over a prolonged time course in a more severe injury model, sciatic nerve transection and reanastamosis. In the neuregulin 1 mutant mice, remyelination was again impaired 2 months after nerve transection and reanastamosis. However, by 3 months post-injury axons lacking neuregulin 1 were effectively remyelinated and virtually indistinguishable from control. Neuregulin 1 signalling is therefore an important factor in nerve repair regulating the rate of remyelination and functional recovery at early phases following injury. In contrast to development, however, the determination of myelination fate following nerve injury is not dependent on axonal neuregulin 1 expression. In the early phase following injury, axonal neuregulin 1 therefore promotes nerve repair, but at late stages other signalling pathways appear to compensate.
Subject(s)
Axons/metabolism , Gene Expression Regulation/genetics , Myelin Sheath/metabolism , Nerve Regeneration/physiology , Neuregulin-1/metabolism , Peripheral Nerve Injuries/physiopathology , Action Potentials/drug effects , Action Potentials/genetics , Analysis of Variance , Animals , Axons/pathology , Axons/ultrastructure , Bromodeoxyuridine/metabolism , Cell Proliferation , Disease Models, Animal , Ganglia, Spinal/metabolism , Gene Expression Profiling , Gene Expression Regulation/drug effects , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Electron , Mutation/genetics , Myelin Proteins/genetics , Myelin Proteins/metabolism , Myelin Sheath/genetics , NAV1.8 Voltage-Gated Sodium Channel/genetics , Nerve Regeneration/drug effects , Nerve Regeneration/genetics , Neuregulin-1/genetics , Oligonucleotide Array Sequence Analysis , Peripheral Nerve Injuries/pathology , Proteins/genetics , RNA, Untranslated , Recovery of Function/genetics , Reflex/drug effects , Reflex/genetics , Sciatic Nerve/metabolism , Sciatic Nerve/pathology , Sciatic Nerve/ultrastructure , Spinal Cord/metabolism , Tamoxifen/pharmacology , Time FactorsABSTRACT
The activity of histaminergic neurons in the tuberomammillary nucleus (TMN) of the hypothalamus correlates with an animal's behavioral state and maintains arousal. We examined how GABAergic inputs onto histaminergic neurons regulate this behavior. A prominent hypothesis, the "flip-flop" model, predicts that increased and sustained GABAergic drive onto these cells promotes sleep. Similarly, because of the histaminergic neurons' key hub-like place in the arousal circuitry, it has also been suggested that anesthetics such as propofol induce loss of consciousness by acting primarily at histaminergic neurons. We tested both these hypotheses in mice by genetically removing ionotropic GABA(A) or metabotropic GABA(B) receptors from histidine decarboxylase-expressing neurons. At the cellular level, histaminergic neurons deficient in synaptic GABA(A) receptors were significantly more excitable and were insensitive to the anesthetic propofol. At the behavioral level, EEG profiles were recorded in nontethered mice over 24 h. Surprisingly, GABAergic transmission onto histaminergic neurons had no effect in regulating the natural sleep-wake cycle and, in the case of GABA(A) receptors, for propofol-induced loss of righting reflex. The latter finding makes it unlikely that the histaminergic TMN has a central role in anesthesia. GABA(B) receptors on histaminergic neurons were dispensable for all behaviors examined. Synaptic inhibition of histaminergic cells by GABA(A) receptors, however, was essential for habituation to a novel environment.
Subject(s)
GABAergic Neurons/physiology , Histamine/metabolism , Neural Inhibition/physiology , Sleep/physiology , Unconsciousness/physiopathology , Wakefulness/physiology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Animals, Newborn , Biophysics , Brain/metabolism , Electric Stimulation , Electroencephalography , Electromyography , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , GABAergic Neurons/drug effects , Green Fluorescent Proteins/genetics , Habituation, Psychophysiologic/genetics , Histidine Decarboxylase/genetics , Histidine Decarboxylase/metabolism , Hypnotics and Sedatives/adverse effects , Hypothalamic Area, Lateral/cytology , In Vitro Techniques , Lysine/analogs & derivatives , Lysine/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Neural Inhibition/drug effects , Neural Inhibition/genetics , Patch-Clamp Techniques , Propofol/adverse effects , Proteins/genetics , Proteins/metabolism , RNA, Messenger/metabolism , RNA, Untranslated , Receptors, GABA-A/deficiency , Reflex/drug effects , Reflex/genetics , Sleep/drug effects , Sleep/genetics , Unconsciousness/chemically induced , Wakefulness/genetics , beta-Galactosidase/metabolismABSTRACT
The brain-derived neurotrophic factor gene (BDNF) is one of many genes thought to influence neuronal survival, synaptic plasticity, and neurogenesis. A common single nucleotide polymorphism (SNP) of the BDNF gene due to valine-to-methionine substitution at codon 66 (BDNF Val66Met) in the normal population has been associated with complex neuronal phenotype, including differences in brain morphology, episodic memory, or cortical plasticity following brain stimulation and is believed to influence synaptic changes following motor learning task. However, the effect of this polymorphism on spinal plasticity remains largely unknown. Here, we used anodal transcutaneous spinal direct current stimulation (tsDCS), a novel noninvasive technique that induces plasticity of spinal neuronal circuits in healthy subjects. To investigate whether the susceptibility of tsDCS probes of spinal plasticity is significantly influenced by BDNF polymorphism, we collected stimulus-response curves of the soleus (Sol) H reflex before, during, at current offset, and 15 min after anodal tsDCS delivered at Th11 (2.5 mA, 15 min, 0.071 mA/cm(2), and 64 mC/cm(2)) in 17 healthy, Met allele carriers and 17 Val homozygotes who were matched for age and sex. Anodal tsDCS induced a progressive leftward shift of recruitment curve of the H reflex during the stimulation that persisted for at least 15 min after current offset in Val/Val individuals. In contrast, this shift was not observed in Met allele carriers. Our findings demonstrate for the first time that the BDNF Val66Met genotype impacts spinal plasticity in humans, as assessed by tsDCS, and may be one factor influencing the natural response of the spinal cord to injury or disease.
Subject(s)
Brain-Derived Neurotrophic Factor/genetics , Neuronal Plasticity/genetics , Polymorphism, Genetic , Reflex/genetics , Spinal Cord/physiology , Adult , Brain-Derived Neurotrophic Factor/physiology , Female , Humans , Male , Muscle, Skeletal/physiology , Neuronal Plasticity/physiology , Reflex/physiology , Transcutaneous Electric Nerve StimulationABSTRACT
Dravet syndrome is an epileptic encephalopathy characterized by multiple types of seizures. We report the first case of musicogenic reflex seizures in a 7-year-old male with a mutation in the SCN1A gene causing Dravet syndrome. Reflex seizures have been reported in patients with Dravet syndrome provoked by body temperature elevation, looking at visual patterns, or under intermittent photic stimulation. The case we report widens the spectrum of reflex seizures recorded in patients with Dravet syndrome. Cortical hyperexcitability of genetic origin could explain the tendency of these patients to experience reflex seizures.
Subject(s)
Epilepsies, Myoclonic/physiopathology , Music , Seizures/physiopathology , Child , Epilepsies, Myoclonic/complications , Epilepsies, Myoclonic/genetics , Humans , Male , Mutation/genetics , NAV1.1 Voltage-Gated Sodium Channel/genetics , Reflex/genetics , Seizures/etiology , Seizures/geneticsABSTRACT
Genes specifically expressed in the inner ear are candidates to underlie hereditary nonsyndromic deafness. The gene Otog has been isolated from a mouse subtractive cDNA cochlear library. It encodes otogelin, an N-glycosylated protein that is present in the acellular membranes covering the six sensory epithelial patches of the inner ear: in the cochlea (the auditory sensory organ), the tectorial membrane (TM) over the organ of Corti; and in the vestibule (the balance sensory organ), the otoconial membranes over the utricular and saccular maculae as well as the cupulae over the cristae ampullares of the three semi-circular canals. These membranes are involved in the mechanotransduction process. Their movement, which is induced by sound in the cochlea or acceleration in the vestibule, results in the deflection of the stereocilia bundle at the apex of the sensory hair cells, which in turn opens the mechanotransduction channels located at the tip of the stereo-cilia. We sought to elucidate the role of otogelin in the auditory and vestibular functions by generating mice with a targeted disruption of Otog. In Otog-/- mice, both the vestibular and the auditory functions were impaired. Histological analysis of these mutants demonstrated that in the vestibule, otogelin is required for the anchoring of the otoconial membranes and cupulae to the neuroepithelia. In the cochlea, ultrastructural analysis of the TM indicated that otogelin is involved in the organization of its fibrillar network. Otogelin is likely to have a role in the resistance of this membrane to sound stimulation. These results support OTOG as a possible candidate gene for a human nonsyndromic form of deafness.
Subject(s)
Deafness/genetics , Ear, Inner/physiopathology , Membrane Glycoproteins/genetics , Postural Balance/physiology , Tectorial Membrane/physiopathology , Acoustic Stimulation , Animals , Chromosome Mapping , Cochlea/physiology , Cochlea/physiopathology , Deafness/pathology , Deafness/physiopathology , Ear, Inner/pathology , Ear, Inner/physiology , Exons , Gene Library , Hearing Disorders/genetics , Hearing Disorders/physiopathology , Humans , Membrane Glycoproteins/deficiency , Membrane Glycoproteins/physiology , Mice , Mice, Knockout , Posture , Reflex/genetics , Stem Cells , Tectorial Membrane/pathology , Tectorial Membrane/ultrastructure , TransfectionABSTRACT
In some situations, animals seem to ignore stimuli which in other contexts elicit a robust response. This attenuation in behavior, which enables animals to ignore a familiar, unreinforced stimulus, is called habituation. Despite the ubiquity of this phenomenon, it is generally poorly understood in terms of the underlying neural circuitry. Hungry fruit flies show a proboscis extension reflex (PER) when sensory receptors are stimulated by sugars. The PER is usually followed by feeding. However, if feeding is disallowed following sugar stimulation, PER is no longer robust, and the animal is considered to be habituated to this stimulus. Our results suggest that PER habituation requires an adenylate cyclase-dependent enhancement of inhibitory output of GABAergic neurons in the subesophageal ganglion (SOG), which mediates PER. GABA synthesis in and release from glutamic acid decarboxylase (GAD1) expressing neurons is necessary, and GABA(A) receptors on cholinergic neurons are required for PER habituation. The proposed inhibitory potentiation requires glutamate/NMDA-receptor signaling, possibly playing a role in stimulus selectivity. We explain why these data provide significant and independent support for a general model in which inhibitory potentiation underlies habituation in multiple neural systems and species.
Subject(s)
Adenylyl Cyclases/metabolism , Drosophila Proteins/metabolism , GABAergic Neurons/physiology , Habituation, Psychophysiologic/genetics , Neural Inhibition/genetics , Neuronal Plasticity/genetics , Adenylyl Cyclases/genetics , Afferent Pathways/physiology , Animals , Animals, Genetically Modified , Brain/metabolism , Carbohydrates/pharmacology , Drosophila , Drosophila Proteins/genetics , GABAergic Neurons/drug effects , Ganglia, Invertebrate/cytology , Gastrointestinal Tract/innervation , Glutamate Decarboxylase/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Neural Inhibition/drug effects , Neuronal Plasticity/drug effects , Physical Stimulation , RNA Interference/physiology , Reflex/genetics , Transcription Factors/genetics , Transcription Factors/metabolismABSTRACT
Biotinidase deficiency is an autosomal recessively inherited disorder characterized by neurological and cutaneous abnormalities. We have developed a transgenic knock-out mouse with biotinidase deficiency to better understand aspects of pathophysiology and natural history of the disorder in humans. Neurological deficits observed in symptomatic mice with biotinidase deficiency are similar to those seen in symptomatic children with the disorder. Using a battery of functional neurological assessment tests, the symptomatic mice performed poorly compared to wild-type mice. Demyelination, axonal degeneration, ventriculomegaly, and corpus callosum compression were found in the brains of untreated, symptomatic enzyme-deficient mice. With biotin treatment, the symptomatic mice improved neurologically and the white matter abnormalities resolved. These functional and anatomical findings and their reversal with biotin therapy are similar to those observed in untreated, symptomatic and treated individuals with biotinidase deficiency. The mouse with biotinidase deficiency appears to be an appropriate animal model in which to study the neurological abnormalities and the effects of treatment of the disorder.
Subject(s)
Biotinidase Deficiency/complications , Demyelinating Diseases/etiology , Nerve Degeneration/etiology , Nervous System Diseases/etiology , Analysis of Variance , Animals , Axons/pathology , Biotinidase/genetics , Biotinidase Deficiency/genetics , Body Weight/genetics , Corpus Callosum/pathology , Demyelinating Diseases/genetics , Disease Models, Animal , Hydrocephalus/diagnosis , Hydrocephalus/etiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Neurons/pathology , Myelin Sheath/genetics , Myelin Sheath/pathology , Nerve Degeneration/genetics , Nervous System Diseases/genetics , Psychomotor Performance/physiology , Reflex/geneticsABSTRACT
Early onset ataxia with ocular motor apraxia and hypoalbuminaemia/ataxia-oculomotor apraxia 1 is a recessively inherited ataxia caused by mutations in the aprataxin gene. We previously reported that patients with frameshift mutations exhibit a more severe phenotype than those with missense mutations. However, reports on genotype-phenotype correlation in early onset ataxia with ocular motor apraxia and hypoalbuminaemia are controversial. To clarify this issue, we studied 58 patients from 39 Japanese families, including 40 patients homozygous for c.689_690insT and nine patients homozygous or compound heterozygous for p.Pro206Leu or p.Val263Gly mutations who were compared with regard to clinical phenotype. We performed Kaplan-Meier analysis and log-rank tests for the ages of onset of gait disturbance and the inability to walk without assistance. The cumulative rate of gait disturbance was lower among patients with p.Pro206Leu or p.Val263Gly mutations than among those homozygous for the c.689_690insT mutation (P=0.001). The cumulative rate of inability to walk without assistance was higher in patients homozygous for the c.689_690insT mutation than in those with p.Pro206Leu or p.Val263Gly mutations (P=0.004). Using a Cox proportional hazards model, we found that the homozygous c.689_690insT mutation was associated with an increased risk for onset of gait disturbance (adjusted hazard ratio: 6.60) and for the inability to walk without assistance (adjusted hazard ratio: 2.99). All patients homozygous for the c.689_690insT mutation presented ocular motor apraxia at <15 years of age. Approximately half the patients homozygous for the c.689_690insT mutation developed cognitive impairment. In contrast, in the patients with p.Pro206Leu or p.Val263Gly mutations, only â¼50% of the patients exhibited ocular motor apraxia and they never developed cognitive impairment. The stepwise multivariate regression analysis using sex, age and the number of c.689_690insT alleles as independent variables revealed that the number of c.689_690insT alleles was independently and negatively correlated with median motor nerve conduction velocities, ulnar motor nerve conduction velocities and values of serum albumin. In the patient with c.[689_690insT]+[840delT], p.[Pro206Leu]+[Pro206Leu] and p.[Pro206Leu]+[Val263Gly] mutations, aprataxin proteins were not detected by an antibody to the N-terminus of aprataxin. Furthermore Pro206Leu and Val263Gly aprataxin proteins are unstable. However, the amount of the 689_690insT aprataxin messenger RNA was also decreased, resulting in more dramatic reduction in the amount of aprataxin protein from the c.689_690insT allele. In conclusion, patients with early onset ataxia with ocular motor apraxia and hypoalbuminaemia homozygous for the c.689_690insT mutation show a more severe phenotype than those with a p.Pro206Leu or p.Val263Gly mutation.
Subject(s)
Ataxia , DNA-Binding Proteins/genetics , Genetic Association Studies , Hypoalbuminemia , Mutation/genetics , Nuclear Proteins/genetics , Ocular Motility Disorders , Action Potentials/genetics , Age of Onset , Ataxia/complications , Ataxia/etiology , Cell Line, Transformed , DNA-Binding Proteins/metabolism , Family Health , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Humans , Hypoalbuminemia/complications , Hypoalbuminemia/genetics , Kaplan-Meier Estimate , Neural Conduction/genetics , Neural Conduction/physiology , Nuclear Proteins/metabolism , Ocular Motility Disorders/complications , Ocular Motility Disorders/genetics , RNA, Messenger/metabolism , Reflex/genetics , Regression Analysis , Tetracycline/pharmacology , Transfection/methodsABSTRACT
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor neurons. To analyze the progressive motor deficits during the course of this disease, we investigated fatigability and ability of recovery of spinal motor neurons by testing monosynaptic reflex transmission with increasing stimulus frequencies in the lumbar spinal cord of the SOD1(G93A) mouse model for ALS in a comparison with wild-type (WT) mice. Monosynaptic reflexes in WT and SOD1(G93A) mice without behavioral deficits showed no difference with respect to their resistance to increasing stimulus frequencies. During the progression of motor deficits in SOD1(G93A) mice, the vulnerability of monosynaptic reflexes to higher frequencies increased, the required time for reflex recovery was extended, and recovery was often incomplete. Fatigability and demand for recovery of spinal motor neurons in SOD1(G93A) mice rose with increasing motor deficits. This supports the assumption that impairment of the energy supply may contribute to the pathogenesis of ALS.